Altair Shareholder Calls For Concentration On Nanotech and Abandonment of Mining - News Item

Lou Schnur, a major shareholder of Altair Nanotechnologies, today called on Altair's directors to instruct management to immediately sell or mothball its chronically unprofitable mining operations and focus exclusively on nanotechnology opportunities.

Altair is a company engaged in developing nanomaterials, titanium dioxide pigment technology, and materials science focused on nanostructures.

Schnur has filed a Schedule 13D with the Securities and Exchange Commission outlining generally the views expressed in this release.

Schnur, a CPA, longstanding Altair investor, and 9.9% beneficial owner of Altair's outstanding stock and warrants, said Altair's mining operations appear to have generated economic losses of $30 million from 1973 through 2003. Also, Schnur criticized the proposed action by Altair to spin off the mining operations as a further distraction and waste of corporate assets.

Schnur said, "The continuing costs to maintain mining personnel and operations, together with attendant legal, accounting and shareholder solicitation costs necessary to implement a spin-off, are economic losers. The assets are carried on Altair's books at zero value, have never produced significant revenues, much less profits, and they should either be sold or mothballed quickly."

Schnur said he supports Altair's December 19, 2003 announcement of a restructuring program whereby the two development stage mining projects would be terminated, so that Altair could focus 100% of its personnel and other resources on its most promising business enterprise, the Reno, Nevada Materials/Nanotechnology Division.

But he says that a March 16, 2004 Altair announcement is contradictory to the stated goals of the restructuring in that there would be a continued focus on mining activities. That release states in part:

"Altair plans to distribute (or spin off) to its shareholders the capital stock of a subsidiary holding the assets of the current Mineral Recovery Systems (MRS) division. Altair intends to solicit shareholder approval for the spin off and complete the filings necessary to make MRS a reporting company. MRS will hold the rights to the exploration-stage mineral deposit in Camden, Tennessee, the ownership of the Altair centrifugal jig and related intellectual property for agglomeration of titanium dioxide.

Dr. William P. Long will resign his position as Chief Executive Officer and member of Altair's board of directors as of May 1, 2004. Dr. Long is expected to serve as the President of MRS ... "

Altair's SEC report on Form 10-K for the fiscal year ended December 31, 2003 disclosed aggregate losses of $17.6 million, by subsidiaries, relating to the centrifugal jig and the Tennessee mining projects. Schnur said he believes the reporting of "subsidiaries losses," as being indicative of total mining losses, is understated and misleading.

Schnur also said, "After reviewing the financial statements in the SEC filings, and as an active shareholder (and a CPA, formerly employed by Price Waterhouse & Co.), it is my opinion that a more realistic economic assessment of Altair's $46 million loss, from inception in 1973 to December 31, 2003 (30 years) is:

     Mining development projects division - 30 years      $30 million

     Reno materials/nanotech division - 3 years           $16 million

     Altair's total loss from 1973 - December 31, 2003    $46 million."

Schnur said he believes shareholder value will be maximized by the immediate termination of mining personnel and of all controllable mining expenditures, and the disposal of the mining projects by public auction, prior to December 31, 2004. The auction should be advertised in "The Northern Miner," with project descriptions mailed to potential interested companies and investors. Altair alumni, suppliers, business prospects and others would have equal opportunity in a public auction.

A definitive, comprehensive disposal of the mining projects will bring closure to a long-term, failed business venture (and to Altair's team of mining directors and managers), maximize Altair's chances for commercial success, and hopefully set the stage for a long overdue return on investments made by Altair shareholders, Schnur said.

To explain his reasoning in estimating Altair's mining losses, Schnur noted that Altair's only business until November 1999 was mining, and that it did not have significant nanotech expenses until 2001. In November 1999, Altair purchased certain technology assets from BHP Minerals International, Inc. (BHP), including, for a one-year period, the services of certain BHP personnel involved in the development of the acquired technology. Accordingly, Altair did not incur salary expenses for the technology operation from November 15, 1999 through November 15, 2000, since these expenses ($1,535,985) were part of the total $9,625,560 purchase price Altair paid BHP.

Altair reported in its Form 10-K for 2000 that it had accumulated deficits during the development stage of $21,606,378, virtually all of which, Schnur says, was attributable to mining.

Posted 22nd April 2003


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Altair Nanotechnologies. (2016, July 20). Altair Shareholder Calls For Concentration On Nanotech and Abandonment of Mining - News Item. AZoNano. Retrieved on June 22, 2024 from

  • MLA

    Altair Nanotechnologies. "Altair Shareholder Calls For Concentration On Nanotech and Abandonment of Mining - News Item". AZoNano. 22 June 2024. <>.

  • Chicago

    Altair Nanotechnologies. "Altair Shareholder Calls For Concentration On Nanotech and Abandonment of Mining - News Item". AZoNano. (accessed June 22, 2024).

  • Harvard

    Altair Nanotechnologies. 2016. Altair Shareholder Calls For Concentration On Nanotech and Abandonment of Mining - News Item. AZoNano, viewed 22 June 2024,

Tell Us What You Think

Do you have a review, update or anything you would like to add to this article?

Leave your feedback
Your comment type

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.